S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
NASDAQ:ABMD

Abiomed Stock Competitors

$352.18
+2.50 (+0.71 %)
(As of 10/22/2021 04:00 PM ET)
Add
Compare
Today's Range
$346.24
$353.77
50-Day Range
$313.87
$376.20
52-Week Range
$242.73
$387.40
Volume113,834 shs
Average Volume258,635 shs
Market Capitalization$15.98 billion
P/E Ratio104.82
Dividend YieldN/A
Beta1.31

Abiomed (NASDAQ:ABMD) Vs. ABT, MDT, ISRG, SYK, EW, BDX, BSX, IDXX, DXCM, and BAX

Should you be buying Abiomed stock or one of its competitors? The main competitors of Abiomed include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Edwards Lifesciences (EW), Becton, Dickinson and (BDX), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), and Baxter International (BAX). These companies are all part of the "health care equipment" industry.

Abiomed vs.

Abiomed (NASDAQ:ABMD) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

90.4% of Abiomed shares are held by institutional investors. Comparatively, 79.6% of Medtronic shares are held by institutional investors. 3.0% of Abiomed shares are held by insiders. Comparatively, 0.5% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Medtronic has higher revenue and earnings than Abiomed.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abiomed$847.52 million18.86$225.52 million$4.9471.29
Medtronic$30.12 billion5.49$3.61 billionN/AN/A

In the previous week, Medtronic had 16 more articles in the media than Abiomed. MarketBeat recorded 20 mentions for Medtronic and 4 mentions for Abiomed. Abiomed's average media sentiment score of 0.44 beat Medtronic's score of 0.17 indicating that Abiomed is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abiomed
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Medtronic
4 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral

Abiomed has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500.

Abiomed presently has a consensus price target of $363.75, suggesting a potential upside of 3.29%. Medtronic has a consensus price target of $144.20, suggesting a potential upside of 17.15%. Given Medtronic's stronger consensus rating and higher probable upside, analysts clearly believe Medtronic is more favorable than Abiomed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abiomed
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Medtronic
0 Sell rating(s)
5 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.80

Medtronic received 1007 more outperform votes than Abiomed when rated by MarketBeat users. Likewise, 79.17% of users gave Medtronic an outperform vote while only 68.38% of users gave Abiomed an outperform vote.

CompanyUnderperformOutperform
AbiomedOutperform Votes
532
68.38%
Underperform Votes
246
31.62%
MedtronicOutperform Votes
1539
79.17%
Underperform Votes
405
20.83%

Abiomed has a net margin of 16.51% compared to Medtronic's net margin of 12.29%. Abiomed's return on equity of 16.35% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
Abiomed 16.51% 16.35% 14.55%
Medtronic 12.29% 13.85% 7.49%

Summary

Abiomed and Medtronic tied by winning 9 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

Abiomed (NASDAQ:ABMD) vs. Its Competitors

TypeAbiomedSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
P/E Ratio104.82101.6133.5528.01
Net Margins16.51%-469.87%-3,885.43%-1,246.18%

Abiomed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABT
Abbott Laboratories
2.8931 of 5 stars
$126.72
+1.3%
$133.61
+5.4%
+17.6%$224.65B$34.61B35.70109,000Earnings Report
Analyst Report
Analyst Revision
News Coverage
MDT
Medtronic
3.0967 of 5 stars
$123.09
+1.2%
$144.20
+17.2%
+10.5%$165.42B$30.12B43.0490,000
ISRG
Intuitive Surgical
2.1498 of 5 stars
$341.52
+0.6%
$335.40
+1.8%
+39.3%$121.91B$4.36B25.528,081Earnings Report
Analyst Report
Analyst Revision
News Coverage
SYK
Stryker
2.7822 of 5 stars
$275.73
+0.3%
$286.43
+3.9%
+24.3%$103.98B$14.35B50.502,020Upcoming Earnings
News Coverage
EW
Edwards Lifesciences
2.2031 of 5 stars
$116.59
+0.7%
$118.44
+1.6%
+45.0%$72.67B$4.39B50.0414,900Upcoming Earnings
BDX
Becton, Dickinson and
2.6309 of 5 stars
$247.09
+0.3%
$273.63
+10.7%
+2.8%$70.96B$17.12B38.7972,000Analyst Upgrade
BSX
Boston Scientific
2.1004 of 5 stars
$44.84
+0.1%
$49.13
+9.6%
+20.6%$63.85B$9.91B135.882,020Upcoming Earnings
IDXX
IDEXX Laboratories
1.9964 of 5 stars
$651.85
+1.0%
$675.00
+3.6%
+51.7%$55.46B$2.71B77.699,300
DXCM
DexCom
2.3562 of 5 stars
$566.57
+0.3%
$516.93
+8.8%
+37.9%$54.82B$1.93B107.925,500Upcoming Earnings
BAX
Baxter International
2.8498 of 5 stars
$82.19
+0.9%
$91.18
+10.9%
+1.4%$41.09B$11.67B37.532,020Upcoming Earnings
RMD
ResMed
2.0765 of 5 stars
$267.50
+1.7%
$241.50
+9.7%
+46.2%$38.97B$3.20B82.567,770Upcoming Earnings
Analyst Upgrade
News Coverage
STE
STERIS
2.4998 of 5 stars
$235.31
+1.3%
$242.40
+3.0%
+25.5%$23.47B$3.11B70.4513,000News Coverage
PODD
Insulet
2.0619 of 5 stars
$304.33
+0.3%
$283.50
+6.8%
+22.0%$20.96B$904.40M-661.591,900
HOLX
Hologic
2.4623 of 5 stars
$73.61
+0.0%
$86.93
+18.1%
+8.4%$18.66B$3.78B9.445,814
TFX
Teleflex
2.5998 of 5 stars
$376.51
+0.5%
$455.80
+21.1%
+2.8%$17.62B$2.54B50.8114,000Upcoming Earnings
News Coverage
MASI
Masimo
1.8898 of 5 stars
$283.35
+0.3%
$292.75
+3.3%
+15.8%$15.60B$1.14B73.412,000Upcoming Earnings
News Coverage
HRC
Hill-Rom
2.3881 of 5 stars
$154.72
+0.1%
$141.80
+8.4%
+67.5%$10.18B$2.88B43.5810,000News Coverage
GMED
Globus Medical
2.3564 of 5 stars
$79.92
+2.0%
$84.80
+6.1%
+48.9%$8.06B$789.04M44.402,200
IART
Integra LifeSciences
1.7777 of 5 stars
$70.82
+0.2%
$75.75
+7.0%
+44.3%$5.99B$1.37B29.393,700
ATRC
AtriCure
2.0989 of 5 stars
$73.13
+1.1%
$89.00
+21.7%
+92.7%$3.36B$206.53M-57.58750News Coverage
ITGR
Integer
2.3531 of 5 stars
$91.61
+0.4%
$106.00
+15.7%
+38.2%$3.02B$1.07B31.277,500Upcoming Earnings
News Coverage
NUVA
NuVasive
1.7381 of 5 stars
$57.57
+0.7%
$66.82
+16.1%
+10.0%$2.97B$1.05B2,879.942,700
CSII
Cardiovascular Systems
2.0481 of 5 stars
$33.88
+0.2%
$44.75
+32.1%
-13.3%$1.37B$258.97M-99.64779Short Interest ↓
Positive News
ATEC
Alphatec
2.4315 of 5 stars
$12.16
+0.6%
$20.92
+72.0%
+27.5%$1.22B$144.86M-9.81296News Coverage
ANGO
AngioDynamics
2.2015 of 5 stars
$28.54
+0.8%
$34.50
+20.9%
+157.8%$1.10B$291.01M-34.80800News Coverage
CRY
CryoLife
2.5414 of 5 stars
$21.04
+0.2%
$35.50
+68.7%
+8.8%$827.50M$253.23M-67.871,200
SRDX
Surmodics
2.4814 of 5 stars
$54.52
+0.6%
$73.00
+33.9%
+33.2%$756.30M$94.86M545.25370News Coverage
OFIX
Orthofix Medical
1.5348 of 5 stars
$35.97
+0.5%
N/A+7.4%$708.43M$406.56M-85.641,036News Coverage
ARAY
Accuray
1.9214 of 5 stars
$4.37
+7.1%
N/A+41.0%$397.05M$396.29M-62.43932Gap Up
IVC
Invacare
1.9698 of 5 stars
$4.68
+0.4%
$9.50
+103.0%
-34.6%$163.84M$850.69M-4.333,400Upcoming Earnings
News Coverage
RMTI
Rockwell Medical
1.6781 of 5 stars
$0.55
+3.6%
$5.00
+807.4%
-42.6%$51.73M$62.20M-1.53300Analyst Downgrade
Short Interest ↓
News Coverage
This page was last updated on 10/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.